Printer Friendly Version

Send to a Friend

Alexandria Real Estate Equities, based in Pasadena, Calif., is planning to construct a $25-million biotech facility at its Seattle Life Sciences complex. The $25-million, 129,000-sf research and development project will replace the 55,000-sf Eklind Hall, the oldest building in the complex. The 10-story building will include five levels of underground parking. Additionally, Alexandria recently spent $35-million to purchase biotech incubator Accelerator Corp.’s Seattle facility. The building is currently under construction with completion expected in October 2003.